Blood Test Detects 90% of Early Dementia Cases šŸ§ šŸ”¬

Muichiro.T

Active member
In a new study, another plasma biomarker in Alzheimerā€™s disease has been identified, the p-tau 217, in combination with amyloid 42/40, a blood test can accurately diagnose Alzheimerā€™s disease with 90% sensitivity compared with 73%, in neurologists, and an impressively low 61%, in primary care physicians. This test assesses the levels of tau protein which refers to amyloid pathology that is critical in Alzheimerā€™s diagnosis. Even though the test seems quite promising in terms of diagnosing the disease at an early stage and with high reliability, it is still not available for the practitioners of primary care. They are not a regular practice yet because more research and validation is still required. Meanwhile, lifestyle modifications and other preventive measures should still be practiced as a great help to cognition.
 
Thatā€™s fascinating! The new plasma biomarker test sounds like a game-changer for early Alzheimerā€™s diagnosis. With its high accuracy, itā€™s a big step forward. While itā€™s not yet widely available, staying on top of lifestyle changes and preventive measures is still crucial.
 
In a new study, another plasma biomarker in Alzheimerā€™s disease has been identified, the p-tau 217, in combination with amyloid 42/40, a blood test can accurately diagnose Alzheimerā€™s disease with 90% sensitivity compared with 73%, in neurologists, and an impressively low 61%, in primary care physicians. This test assesses the levels of tau protein which refers to amyloid pathology that is critical in Alzheimerā€™s diagnosis. Even though the test seems quite promising in terms of diagnosing the disease at an early stage and with high reliability, it is still not available for the practitioners of primary care. They are not a regular practice yet because more research and validation is still required. Meanwhile, lifestyle modifications and other preventive measures should still be practiced as a great help to cognition.
It's amazing how advancements like the p-tau 217 test could boost diagnostic accuracy so much, though it's a bummer it's not yet available for primary care. Thanks for sharing this insight! šŸ™Œ
 
Totally agreeā€”this new plasma biomarker test could be a huge breakthrough for early Alzheimerā€™s diagnosis, and staying proactive with lifestyle changes is definitely key! Thanks for the heads-up on this, really appreciate it! šŸ˜Š
Thatā€™s fascinating! The new plasma biomarker test sounds like a game-changer for early Alzheimerā€™s diagnosis. With its high accuracy, itā€™s a big step forward. While itā€™s not yet widely available, staying on top of lifestyle changes and preventive measures is still crucial.
 
It's amazing how advancements like the p-tau 217 test could boost diagnostic accuracy so much, though it's a bummer it's not yet available for primary care. Thanks for sharing this insight! šŸ™Œ
It's so cool how the p-tau 217 test could revolutionize diagnostics, though itā€™s a bit of a letdown that we can't get it in primary care yet. Thanks a ton for sharing this info, super appreciated! šŸ™ŒšŸ§ 
 
Back
Top